CD4 and metabolic dysfunction-associated steatohepatitis: Furthermore, our observations indicate a reduction of PD-1+ CD4 Tconv cells in VAT of obese patients with dysglycemic and an augmentation in the liver of individuals with NASH and type 2 diabetes.